论文信息 - 339 Immune profiling to investigate improved survival in patients with metastatic triple-negative breast cancer receiving trilaciclib prior to chemotherapy - 字舞流文

339 Immune profiling to investigate improved survival in patients with metastatic triple-negative breast cancer receiving trilaciclib prior to chemotherapy

A. Tan | J. O’Shaughnessy | J. Sorrentino | J. Horton | Aaron D. Stevens | J. Yi | Subing Cao